Resumen de Incidence, clinical outcomes, and therapeutic approaches of capsule endoscopy-related adverse events in a large study population

Ignacio Fernández Urién Sáinz, Cristina Carretero Ribón, Begoña González Suárez, Vicente Pons, Ángel Caunedo Álvarez, Julio Valle Muñoz, Eduardo Redondo Cerezo, Antonio López Higueras, Mariano Valdés Chávarri, Pedro Menchén, Pedro Fernández, Miguel Ángel Muñoz Navas, Javier Jiménez, Juan Manuel Herrerías Gutiérrez

• Introduction: Capsule endoscopy (CE) has become a first-line tool for small bowel (SB) examination. However, adverse events (AEs), such as CE retention or aspiration, may occur. The aims of this study were to evaluate incidence, clinical outcomes and therapeutic approaches of CE-related AEs in the largest series published to date.

  Methods: Data from 5428 procedures performed at 12 institutions between August 2001 and January 2012 were retrospectively analyzed. Baseline patient characteristics; procedure;

  type, localization and symptoms before/after AEs; previous patency tests performed; therapeutic management and patient´s outcome were recorded.

  Results: The overall incidence of CE-related AEs was 1.9%:

  2.0% for SB, 0.9% for esophageal and 0.5% for colon CE. The incidence of capsule retention was significantly higher than capsule aspiration (1.87% vs. 0.003%; p < 0.05), in patients suffering from inflammatory bowel disease (IBD) than in obscure GI bleeding (OGIB) (3.3% vs. 1.5%; p < 0.05) and in patients with the combination of nausea/vomiting, abdominal pain and distension. The SB was the most frequent localization of retention (88.2%). The use of patency tests -except for Patency© capsule- before CE was not a good predictor for AEs. Most of the patients with AEs developed no or mild symptoms (97%) and were managed by non-surgical methods (64.4%).

  Conclusions: CE-related AEs are uncommon and difficult to predict by imagiological examinations. SB retention, that is usually asymptomatic, is the most frequent AE. In absence of symptoms, non-surgical management of CE-related AEs is recommended.